Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter [Phase 2, Phase 3]
This update reports the completion of a randomized, double-blind, placebo-controlled, dose-ranging study evaluating SSR149744C (50, 100, 200…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr [Phase 2]
A Phase 2 double-blind, placebo-controlled dose-ranging trial evaluated SSR149744c at 300 mg or 600 mg for converting atrial fibrillation or…
-
CLINICAL_TRIALS withdrawal · 2012-05-07Clinical Trial Update: Comparison of External Event Recorders for Atrial Fibrillation Monitoring [NA]
The clinical trial comparing external event recorders for atrial fibrillation monitoring has been withdrawn.
-
FDA approval · 2012-04-27FDA Approved: DIGOXIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Digoxin submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: "UNMASKING Study" For Atrial Fibrillation Recurrences Typing in Early Postoperative Period [Phase 3]
Phase 3 UNMASKING Study update on typing of atrial fibrillation recurrences in the early postoperative period; the trial status is completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Pulmonary Vein Ablation of Atrial Fibrillation Using Magnetic Navigation: Single Ring Versus Circumferential Techniques [NA]
This clinical trial update indicates completion of a study comparing single-ring versus circumferential magnetic navigation approaches for p…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation [Phase 3]
Phase 3 trial results evaluate rivaroxaban for prevention of stroke in patients with non-valvular atrial fibrillation, showing efficacy and …
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon [Phase 4]
A Phase 4 trial update reports completion of a study to determine the appropriate initial dosing of phenprocoumon in patients with pulmonary…
-
FDA approval · 2012-03-27FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for Jantoven (warfarin sodium) submitted by Upsher-Smith Laboratories.
-
CLINICAL_TRIALS safety_alert · 2012-03-21Clinical Trial Update: Safety of Amiodarone and Ranolazine Together in Patients With Angina [Phase 4]
Phase 4 clinical trial update evaluating the safety of co-administering amiodarone and ranolazine in patients with angina and related cardio…
-
CLINICAL_TRIALS trial_result · 2012-03-20Clinical Trial Update: Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making [Phase 1]
Phase 1 clinical trial update focused on improving atrial fibrillation care by promoting patient-centered decision making.
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: Long-term Safety in Atrial Fibrillation Patients [Phase 2]
A Phase 2 long-term safety trial in patients with persistent or permanent nonvalvular atrial fibrillation has completed and results have bee…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Efficacy Study for Surgery After Previous Failed Catheter Ablation
This update notes the completion of an efficacy study evaluating surgery for atrial fibrillation patients after a previous failed catheter a…
-
CLINICAL_TRIALS research · 2012-02-20Clinical Trial Update: The RECORD Asia-Pacific Atrial Fibrillation Registry
This document provides an update on the RECORD Asia-Pacific Atrial Fibrillation Registry sponsored by Sanofi. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion [Phase 2]
Phase 2 trial of eplerenone to prevent recurrences of atrial fibrillation after cardioversion has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG [NA]
Completed clinical trial evaluating a routine mini-invasive electrophysiology study for patients with tachycardia and a negative Holter ECG.
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305 [Phase 2]
Phase 2 trial results for intravenous AZD1305 in atrial fibrillation; the study was completed and results posted.
-
CLINICAL_TRIALS research · 2012-02-01Clinical Trial Update: Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage [NA]
This clinical trial update investigates atrial and brain natriuretic peptide secretion after percutaneous closure of the left atrial appenda…
-
CLINICAL_TRIALS research · 2012-01-31Clinical Trial Update: Ibutilide Administration During Pulmonary Vein Ablation [NA]
Clinical trial update regarding administration of ibutilide during pulmonary vein ablation for atrial fibrillation; current trial status is …
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for propranolol hydrochloride, indicating the generic product's supplemental filing h…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Explorative Study of AZD1305 in Atrial Fibrillation Patients [Phase 2]
This document reports the completion and results posting of an exploratory Phase 2 trial of AZD1305 in patients with atrial fibrillation.
-
FDA approval · 2012-01-25FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Multaq (dronedarone) filed by Sanofi-Aventis U.S. LLC. The drug is the brand Multaq with generic…
-
CLINICAL_TRIALS research · 2012-01-25Clinical Trial Update: Concomitant Treatment of Permanent Atrial Fibrillation [Phase 3]
Phase 3 clinical trial update on concomitant treatment of permanent atrial fibrillation conducted by AtriCure; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation [Phase 4]
A Phase 4 clinical trial evaluating the optimal timing of initiating dronedarone after conversion in patients with persistent atrial fibrill…
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery [Phase 1]
A Phase 1 clinical trial evaluating remote ischemic preconditioning to improve cardiac function after cardiac surgery has been withdrawn. Th…